results in the range 0.1-0.35 kU/L had been associated with clinically significant food allergy (and positive skin prick testing) in our cohort.
Results: From the cohort of 435 patients (predominantly children with a median age of 6) whose medical records were analysed, 13 patients were identified who had had a clinical reaction to an allergen with an IgE in the range of 0.1-0.35kU/L. They were also all found to be skin prick test positive for the allergen of interest. Irrespective of the clinical history, 54 patients had a positive skin prick test when their IgE result was between 0.1 and 0.35 kU/L, while 62 patients had a negative result. Allergens most likely to have positive skin prick testing with IgE in the 0.1-0.35 kU/L range were nuts and cow's milk.
Conclusion:
Our results suggest that allergen specific IgE results for foods ranging from 0.1 to 0.35 kU/L can be associated with clinically significant food allergy and positive SPT, particularly in children.
P9 SIMULTANEOUS DETECTION OF MAJOR FOOD ALLERGENS USING FLUORESCENT MULTIPLEX ARRAY
Stephanie Filep, Bryan Smith, Kristina Reid Black, Jessica Lee, Brian Murphy, Denise Block and Martin Chapman INDOOR Biotechnologies, Inc., Charlottesville, VA, USA Background: Quantification of food allergens is increasingly important for dose assessments of food preparations used in oral immunotherapy (OIT), food allergy prevention, and monitoring safety in the food industry. 'Generic' immunoassays for 'total protein' do not measure specific allergens. Our aim was to develop and validate a multiplex immunoassay capable of simultaneously measuring major food allergens from peanut, cow's milk, shellfish, egg, cashew, hazelnut and soy.
Method: The multiplex array was developed on the Luminex xMAP system. Microspheres coupled to specific monoclonal antibodies were used for allergen capture. Biotinylated specific monoclonal or polyclonal antibodies were used for detection. Reference standards formulated from natural or recombinant allergens, with purity established by mass spectrometry. A full method validation was performed to determine parameters of linearity, range, limits of quantification and detection, accuracy and precision of the multiplex food immunoassay.
Results: Full method validations were completed for peanut (Ara h 3, Ara h 6), cow's milk (Bos d 5), shrimp tropomyosin, egg (Gal d 2), cashew (Ana o 3), hazelnut (Cor a 9) and soy (Gly m 5). The standard curves for all analytes allow for quantification over a large dynamic range. The lower limits of detection (LLOD) were as low as 0.02ng/ml and 0.06ng/ml. Intra-and interassay accuracy and precision results for three samples assayed in triplicate on four occasions passed acceptance criteria within the range of 70-130% recovery and a coefficient of variation of <15%. The multiplex array simultaneously measured 8 major food allergens in several food sources.
Conclusion: A quantitative, accurate and precise multiplex immunoassay was validated for the simultaneous detection of major food allergens. The multiplex array provides a sensitive and efficient tool for measuring specific food allergens, as opposed to generic food source proteins, with potential application for risk assessment in the food industry.
P10 OUTCOME OF MULTIPLE NUT ORAL FOOD CHALLENGES

Jessica Lai and Dianne Campbell
The Children's Hospital at Westmead, Sydney, New South Wales, Australia Background and aim: Many allergic children avoid all nuts rather than their specific trigger allergen due to sensitisation to other tree nuts. Traditionally, tree nut oral food challenges (OFCs) in this context are performed with a series of single challenges, however this is time consuming with long waiting lists. We sought to assess outcomes, effectiveness and utility of multiple nut-OFCs (MN-OFCs).
Method: A retrospective study of MN-OFCs at The Children's Hospital at Westmead, January 2015 -July 2016 was undertaken. Children were assessed for suitability for a MN-OFC by standardised criteria. The perceived usefulness, dietary incorporation and tolerance of the MN-OFC was assessed by parent questionnaire, sent to parents at least 6 months after the MN-OFC.
Results: 106 children underwent MN-OFCs. 62% were male. The median age was 10 (IQR 6-12). 7 children had generalised allergic reactions including one anaphylaxis. Most MN-OFCs included 3 nuts; the most common nuts included were almond, hazelnut and macadamia. The median cumulative protein dose for each challenged nut was 2.9g (IQR 1.8g-4.0g). 54 (51%) parents completed the questionnaire. Of those, 94% reported MN-OFC was at least a little bit useful, 85% found it very useful. 5 children reported symptoms at home, however only in 2 instances were these nuts discontinued. 65% of nuts challenged were still consumed regularly, most commonly cashew. 37% of responding parents did not accurately recall which nuts were challenged and 10% could not accurately recall the OFC outcome.
Conclusion:
The rate of allergic reaction in this low risk cohort was low. The majority of responding parents reported MN-OFCs to be useful. Almost two thirds of their children continued to eat the challenged nut 6 months post OFC, where tolerant at OFC. Of concern, of those who returned the questionnaire, parental recall regarding the details of the MN-OFC was poor. Rationale: Australia has one of the highest paediatric peanut allergy rates in the world (3%), and many of the peanut allergic patients also show allergies to tree nuts. The clinical cross-reactivity between peanut and tree nuts is thought to be contributed by highly cross-reactive, repeat peptide motifs within and among nuts. To test this hypothesis, this study aims to identify linear epitopes and cross-reactivity of anti-Ara h 2 monoclonal antibodies using the peptide microarray and assess their ability to inhibit IgE binding to the specific linear epitopes.
P11 CROSS-REACTIVITY OF ANTI-ARA H2 MONOCLONAL ANTIBODIES WITH ALLERGENS IN PEANUT, TREE NUTS AND LEGUMES
Nanju Alice Lee
Methods: Seven anti-Ara h 2 monoclonal antibodies were epitopemapped using the peptide microarray. The cross-reactivity of the monoclonal antibodies with other peanut allergens, and allergens of tree nuts and legumes were assessed on the same microarray. The selected monoclonal antibodies were tested for their ability to compete with IgE binding for the identified epitopes on the microarray.
Results: The anti-Ara h 2 monoclonal antibodies made against surfaceexposed areas of native Ara h 2 recognised three regions adjoining alphahelix and beta-strand on Ara h2. Despite their monoclonal nature, these antibodies recognsed specific peptides on other peanut allergens, as well as 2S albumins, 7S globulins, 11S globulins and lipid transfer proteins of tree nuts and legumes. The selected antibodies were able to compete for IgE binding to the epitopes with low binding.
Conclusion:
We demonstrated that highly specific anti-Ara h 2 monoclonal antibodies cross-reacted with specific peptides in other peanut allergens, as well as 2S albumins, 7S globulins, 11S globulins and lipid transfer proteins of tree nuts and legumes. These antibodies inhibited IgE binding to the specific linear epitopes with low affinity. 
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